A newly identified genetic risk factor for heart block after surgery may help guide the course of postoperative care.
James Crowe Jr., M.D., director of the Vanderbilt Vaccine Center, is the 2017 recipient of the Stanley J. Korsmeyer Award given by the American Society for Clinical Investigation (ASCI), one of the nation’s oldest and most respected honor societies for physician-scientists.
S. Todd Callahan, M.D., MPH, associate professor of Pediatrics, has been named director of the Division of Adolescent and Young Adult Health.
James Crowe Jr., M.D., director of the Vanderbilt Vaccine Center, is the 2017-2018 recipient of the Samuel Rosenthal Prize for Excellence in Academic Pediatrics.
The protein beta-catenin may be a good target for therapies to treat lung disease that is a common complication of preterm birth.
Two factors commonly used to evaluate patients with sickle cell disease are associated with each other and can predict increased mortality, Vanderbilt researchers have discovered.